SCHEMBL8588052

SCHEMBL8588052

O=C1Nc2ccc(OCC(O)CO)cc2C1=Cc1cc2ccccc2[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K1 Q92918 3/20 0.44
▸ NTRK1 P04629 2/20 0.43
▸ SIRT1 Q96EB6 1/20 0.43
▸ LRRK2 Q5S007 4/20 0.43
▸ TLK2 Q86UE8 3/20 0.42
▸ PDPK1 O15530 1/20 0.42
▸ PAK4 O96013 7/20 0.41
▸ LCK P06239 3/20 0.40
▸ RET P07949 3/20 0.40
▸ PDGFRA P16234 3/20 0.40
▸ KDR P35968 3/20 0.40
▸ ALK Q9UM73 3/20 0.40
▸ PDE3B Q13370 1/20 0.40
▸ PDE3A Q14432 1/20 0.40
▸ P2RY12 Q9H244 1/20 0.40
▸ CHEK1 O14757 2/20 0.40
▸ AURKA O14965 1/20 0.40
▸ DAPK3 O43293 1/20 0.40
▸ JAK2 O60674 1/20 0.40
▸ PRKD3 O94806 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8588039 1.00 MAP4K1 (0.44) MAP4K1NTRK1SIRT1LRRK2TLK2
SCHEMBL8529701 0.83 KDM4E (0.47) NTRK1LRRK2RETKDRIGF1R
SCHEMBL5361502 0.82 PDPK1 (0.64) NTRK1TLK2PDPK1PAK4RET
SCHEMBL8584320 0.81 NTRK1 (0.47) MAP4K1NTRK1SIRT1TLK2PDPK1
SCHEMBL8584332 0.81 NTRK1 (0.47) MAP4K1NTRK1SIRT1TLK2PDPK1
SCHEMBL3485635 0.80 TLK2 (0.64) MAP4K1NTRK1SIRT1LRRK2TLK2
SCHEMBL8586257 0.80 NTRK1 (0.57) MAP4K1NTRK1LRRK2PDPK1PAK4
SCHEMBL8586259 0.80 NTRK1 (0.57) MAP4K1NTRK1LRRK2PDPK1PAK4
SCHEMBL5364426 0.77 RET (0.67) NTRK1TLK2PDPK1PAK4LCK
SCHEMBL8528465 0.76 DHFR (0.42) NTRK1TLK2PDPK1PAK4LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5840745-A INHIBITING CELL PROLIFERATION, TUMOR GROWTH, METASTASIS, DEVELOPMENT OF ATHEROMATOUS PLAQUE AND RESTENOSIS, CONTROLLING ANGIOGENESIS, TREATING DIABETES, ENHANCING CANCER THERAPY PHARMACIA S. P. A. (IT) 1998-11-24 — — US claimed
US-5840745-A INHIBITING CELL PROLIFERATION, TUMOR GROWTH, METASTASIS, DEVELOPMENT OF ATHEROMATOUS PLAQUE AND RESTENOSIS, CONTROLLING ANGIOGENESIS, TREATING DIABETES, ENHANCING CANCER THERAPY PHARMACIA S. P. A. (IT) 1998-11-24 — — US disclosed
Send feedback